24/7 Market News Snapshot 13 May, 2025 – Redhill Biopharma Ltd. (NASDAQ:RDHL)

May 13, 2025

DENVER, Colo., 13 May, 2025 (www.247marketnews.com) – (NASDAQ:RDHL) are discussed in this article.
RedHill Biopharma Ltd. (NASDAQ:RDHL) has recently experienced an uptick in its stock performance, with trading values reaching $2.050 in pre-market activity, representing a 2.50% increase from the previous close of $2.000. This positive momentum is underscored by a trading volume of 2.00 million shares, indicating robust investor interest and the potential for further gains. Analysts suggest that a breakthrough above critical resistance levels could catalyze additional upward movement in the stock.

In addition to its market activity, RedHill achieved a notable legal victory against Kukbo Co. Ltd., as the New York Supreme Court issued a summary judgment in favor of RedHill, amounting to approximately $8.25 million, which includes legal fees and accrued interest. The court ruling has further solidified RedHill’s position by dismissing all counterclaims from Kukbo. The Incheon District Court in South Korea has also granted an attachment order, aimed at safeguarding RedHill’s interests by preventing Kukbo from liquidating its assets while the enforcement of the ruling is underway.

This legal triumph stems from Kukbo’s non-compliance with subscription and licensing agreements made during 2021 and 2022. As RedHill moves forward to collect the awarded amount, it maintains the right to pursue additional costs incurred during the legal proceedings, while preparing for potential appeals from Kukbo.

These developments reflect RedHill Biopharma’s strong commitment to advancing its innovative treatments in gastrointestinal diseases, infectious diseases, and oncology. With FDA-approved products like Talicia® in its pipeline, RedHill remains poised for continued growth, solidifying its position as a key player in the pharmaceutical industry amidst favorable market conditions and successful legal outcomes.

Related news for (RDHL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.